Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis

References

• Pötter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116–123.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Fokdal LU, Nielsen SK, et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013;52(7):1510–1519.
   PubMed Web of Science ®Google Scholar
• Nomden CN, de Leeuw AAC, Roesink JM, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol. 2013;107(1):69–74.
   PubMed Web of Science ®Google Scholar
• Rijkmans EC, Nout RA, Rutten IHHM, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol. 2014;135(2):231–238.
   PubMed Web of Science ®Google Scholar
• Castelnau-Marchand P, Chargari C, Maroun P, et al. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer. Gynecol Oncol. 2015;139(2):288–294.
   PubMed Web of Science ®Google Scholar
• Gill BS, Kim H, Houser CJ, et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the 8university of Pittsburgh experience. Int J Radiat Oncol Biol Phys. 2015;91(3):540–547.
   PubMed Web of Science ®Google Scholar
• Lakosi F, de Cuypere M, Viet Nguyen P, et al. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: a mono-institutional experience. Acta Oncol. 2015;54(9):1558–1559.
   PubMed Web of Science ®Google Scholar
• Ribeiro I, Janssen H, De Brabandere M, et al. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Radiother Oncol. 2016;120(3):447–454.
   PubMed Web of Science ®Google Scholar
• Sturdza A, Pötter R, Fokdal LU, et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120(3):428–433.
   PubMed Web of Science ®Google Scholar
• Pötter R, Tanderup K, Schmid MP, et al.; EMBRACE Collaborative Group. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538–547.
   PubMed Web of Science ®Google Scholar
• Jürgenliemk-Schulz IM, Beriwal S, de Leeuw AAC, et al. Management of nodal disease in advanced cervical cancer. Semin Radiat Oncol. 2019;29(2):158–165.
   PubMed Web of Science ®Google Scholar
• Nomden CN, Pötter R, de Leeuw AAC, et al.; EMBRACE Collaborative Group. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: patterns of failure in the EMBRACE study cohort. Radiother Oncol. 2019;134:185–190.
   PubMed Web of Science ®Google Scholar
• Ayatilakebanda I, Tsang YM, Hoskin P. High dose simultaneous integrated boost for node positive cervical cancer. Radiat Oncol. 2021;16(1):1–7.
   PubMed Web of Science ®Google Scholar
• Ramlov A, Assenholt MS, Jensen MF, et al. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiother Oncol. 2017;123(1):158–163.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Assenholt M, Ramlov A, et al. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer. Acta Oncol. 2017;56(11):1479–1486.
   PubMed Web of Science ®Google Scholar
• Pötter R, Tanderup K, Kirisits C, et al.; EMBRACE Collaborative Group. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60.
   PubMed Web of Science ®Google Scholar
• Berger T, Fokdal LU, Assenholt MS, et al. Robustness of elective lymph node target coverage with shrinking planning target volume margins in external beam radiotherapy of locally advanced cervical cancer. Phys Imaging Radiat Oncol. 2019;11:9–15.
   PubMedGoogle Scholar
• ICRU Report 89 Prescribing, Recording and reporting brachytherapy for cancer of the cervix: International Commission of Radiation Unit and Measurement. Vol. 13. Oxford (UK): Oxford University Press; 2013. p. 133–141.
   Google Scholar
• Edwards JK, Hester LL, Gokhale M, et al. Methodologic issues when estimating risks in pharmacoepidemiology. Curr Epidemiol Rep. 2016;3(4):285–296.
   PubMedGoogle Scholar
• Ramlov A, Kroon PS, Jürgenliemk-Schulz IM, et al. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer. Acta Oncol. 2015;54(9):1567–1573.
   PubMed Web of Science ®Google Scholar
• Bacorro W, Dumas I, Escande A, et al. Dose–volume effects in pathologic lymph nodes in locally advanced cervical cancer. Gynecol Oncol. 2018;148(3):461–467.
   PubMed Web of Science ®Google Scholar